A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

Two squirts of a nasal spray made from stem-cell particles dialed back inflammatory markers of brain aging in middle-aged ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...

Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...

ER-100 is being tested to restore vision by resetting the biological age of eye cells through epigenetic reprogramming, ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.